Clinical evolution and outcomes | Conventional Bacteria (N = 163) | Atypical Agents (N = 151) | Virus (N = 41) | Mixed Infection (N = 35) | Pvalue║ |
---|---|---|---|---|---|
Clinical evolution | |||||
Treatment failure | 15 (9.2) | 8 (5.3) | 0 (0) | 1 (2.9) | 0.1 |
Severe sepsis | 71 (43.8) | 22 (14.6) | 6 (14.6) | 6 (17.1) | <0.0001 |
Septic shock | 8 (4.9) | 1 (0.7) | 0 (0) | 0 (0) | 0.04 |
Hospitalized | 123 (75.5) | 39 (25.8) | 13 (31.7) | 21 (60) | <0.0001 |
Admission to intensive care unit | 14 (8.6) | 1 (0.7) | 0 (0) | 0 (0) | 0.0007 |
Use of mechanical ventilation | 2 (1.2) | 1 (0.7) | 0 (0) | 0 (0) | 0.8 |
Outcomes | |||||
Mortality within 30 days | 7 (4.3) | 2 (1.3) | 0 (0) | 0 (0) | 0.2 |
In-hospital mortality* | 5 (4.1) | 2 (5.1) | 0 (0) | 0 (0) | 0.7 |
Readmission within 30 days* | 10 (8.1) | 2 (5.1) | 0 (0) | 2 (9.5) | 0.7 |
Length of hospital stay*† (days) | |||||
Mean (SD) | 3.9 (3.1) | 3 (2.7) | 2.9 (2) | 2.9 (2.4) | 0.05 |
>3 | 57 (48.3) | 8 (21.6) | 4 (30.8) | 5 (23.8) | 0.01 |
Return to daily activity†, mean (SD),days | 19.5 (9.1) | 19.6 (11) | 21.6 (11.5) | 17.8 (11.1) | 0.3 |
Subsequent hospitalization‡ | 1 (2.6) | 3 (2.7) | 1 (3.6) | 1 (7.1) | 0.8 |